In 2026, Imdad continues to grow with a clear purpose: to help our partners build successful practices and deliver outstanding patient care. This year, we have further expanded our portfolio with Candela’s Vbeam Pro for vascular dermatology, Pallas Premium for targeted treatment of psoriasis, vitiligo and other inflammatory skin conditions, and BELLUS-Q, a versatile Q-switched laser for pigmentation, tattoo removal and skin rejuvenation. These additions strengthen the exceptional selection of technologies we offer to physicians establishing or expanding dermatology and aesthetic practices across the region.
Our commitment extends throughout the life of every technology we provide. Through our dedicated biomedical engineering teams, comprehensive maintenance and service contracts, and best-in-class marketing support, we help our partners maintain reliable operations, build patient demand and achieve sustainable practice growth. We also continuously refine our clinical protocols and training to help medical teams make optimal use of their technologies and deliver the best possible outcomes for their patients.
As we strengthen our regional presence and operations, we remain guided by the trust of our customers, the dedication of our people and a shared belief in the future of dermatology and aesthetic medicine. I thank our partners for their continued confidence in Imdad and look forward to a positive year of progress, opportunity and shared success.